Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06541652
What this trial is testing

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Who this might be right for
HepatocholangiocarcinomaFibrolamellar CarcinomaHepatic Epithelioid Hemangioendothelioma+7 more
Federation Francophone de Cancerologie Digestive 150
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Early research (Phase 1)UnknownNCT00160836
What this trial is testing

Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter

Who this might be right for
Pancreatic NeoplasmsCholangiocarcinomaPancreatitis
University Hospital, Geneva 68
Not applicableEnded earlyNCT02256982
What this trial is testing

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic CholangiocarcinomaResectable Intrahepatic Cholangiocarcinoma
Massachusetts General Hospital 3
Testing effectiveness (Phase 2)Study completedNCT04256980
What this trial is testing

Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement

Who this might be right for
Cholangiocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 34
Testing effectiveness (Phase 2)Study completedNCT00779454
What this trial is testing

Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Vejle Hospital 72
Not applicableUnknownNCT04386772
What this trial is testing

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Who this might be right for
Portal Vein OcclusionCholangiocarcinoma, PerihilarHepatocellular Carcinoma+1 more
Eastern Hepatobiliary Surgery Hospital 56
Testing effectiveness (Phase 2)WithdrawnNCT04895046
What this trial is testing

Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma

Who this might be right for
HRDCholangiocarcinomaMetastatic Cancer
Walid Shaib, MD
Testing effectiveness (Phase 2)Study completedNCT03895970
What this trial is testing

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Who this might be right for
Liver Neoplasm Malignant PrimaryCholangiocarcinomaCombinational Immunotherapy+1 more
Peking Union Medical College Hospital 32
Not applicableLooking for participantsNCT07717437
What this trial is testing

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Who this might be right for
Liver CancerLiver Metastases
Maastricht University Medical Center 350
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06178445
What this trial is testing

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerHER2 Gene MutationHER2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 24
Not applicableUnknownNCT05718349
What this trial is testing

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Who this might be right for
CholestasisIcterusCholangiocarcinoma+2 more
Nicole Hildebrand 81
Testing effectiveness (Phase 2)Looking for participantsNCT05967182
What this trial is testing

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02609958
What this trial is testing

ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy

Who this might be right for
Cholangiocarcinoma
ASLAN Pharmaceuticals 32
Not applicableStudy completedNCT01145248
What this trial is testing

Comparison of Biliary Forceps Biopsy and Brush Cytology

Who this might be right for
Cholangiocarcinoma
University of Ulm 43
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Not applicableStudy completedNCT07225452
What this trial is testing

An Exosomal miRNA-based Liquid Biopsy for ICC Detection

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
City of Hope Medical Center 535
Testing effectiveness (Phase 2)Study completedNCT01206049
What this trial is testing

Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations

Who this might be right for
Cholangiocarcinoma
Vejle Hospital 88
Large-scale testing (Phase 3)UnknownNCT01470443
What this trial is testing

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
Samsung Medical Center 240
Next Page